Market Research Report
Biodegradable Stents: Global Markets
|Published by||BCC Research||Product code||819218|
|Published||Content info||102 Pages
Delivery time: 1-2 business days
|Biodegradable Stents: Global Markets|
|Published: April 4, 2019||Content info: 102 Pages||
The global market for biodegradable stents should grow from $106.7 million in 2018 to $378.0 million by 2023 with a compound annual growth rate (CAGR) of 28.8% for the period of 2018-2023.
The European Union (EU) market for biodegradable stents should grow from $82.3 million in 2018 to $165.4 million by 2023 with a CAGR of 15.0% for the period of 2018-2023.
The Asia-Pacific market for biodegradable stents should grow from $20.4 million in 2018 to $108.4 million by 2023 with a CAGR of 39.7% for the period of 2018-2023.
This report reviews both global and regional markets of the biodegradable stents market according to available types and application areas. The report analyzes the current market status and trends, and provides growth forecasts for the five-year period 2018 to 2023. The analysis also discusses R&D issues, including global regulatory scenarios and other commercialization hurdles. Additionally, this comprehensive report examines technology developers/manufacturers of biodegradable stents, their product types and geographical product presence (wherever data is available).
The biodegradable stents market is divided into the following types -
The report differentiates BDS from conventional metallic DES that have a matrix coating of bioresorbable polymer and antiproliferative drug. These devices, which have typical metallic nondegradable stent backbones, are known as bioresorbable polymer DES, bioabsorbable polymer DES or biodegradable polymer DES. Therefore, this report concentrates only on the BDS market for fully bioabsorbable or biodegradable stents.
The only applications of the biodegradable stent market that have been analyzed in this report includes -
The report also offers a detailed patent analysis with information on the strategic initiatives of market players within the past five years.
The report specifically excludes stents that are not fully biodegradable and also stents that have bioabsorbable coatings which are not fully bioabsorbable. The report also excludes biomaterial technology/product and equipment providers.
Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.